WestEnd Advisors’s Xylem XYL Stock Holding History

WestEnd Advisors’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	-$119	–	392
2021 Q4	$119	Buy	+1	New	+$124	﹤0.01%	328
2021 Q3	–	Hold	0	–	–	–	306
2021 Q2	–	Hold	0	–	–	–	311

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WestEnd Advisors's XYL Position: Q1 2022 in Review

WestEnd Advisors sold out of Xylem (XYL) in Q1 2022, closing a stake of 1 share — an estimated $119 sold.

WestEnd Advisors first reported a position in XYL in Q4 2021 and held it in 1 quarter. The position peaked at $119 in Q4 2021. 759 funds tracked by Wall St. Rank hold XYL as of Q1 2022.

WestEnd Advisors reported no remaining Xylem position as of Q1 2022 after selling out during the quarter.
WestEnd Advisors sold 1 Xylem share in Q1 2022, an estimated $119.
WestEnd Advisors first reported a position in Xylem in Q4 2021 and held it in 1 quarter.
WestEnd Advisors's Xylem position peaked at $119 in Q4 2021.
759 funds tracked by Wall St. Rank held Xylem as of Q1 2022.

Based on WestEnd Advisors's 13F filing for Q1 2022, filed 26 Apr 2022.